Package | Dosage | Price | Price per Dose | |
---|---|---|---|---|
Dosage: 7,5mg | ||||
360 pill | 7,5mg | NZD560.21 | NZD1.55 | |
270 pill | 7,5mg | NZD450.43 | NZD1.67 | |
180 pill | 7,5mg | NZD306.59 | NZD1.70 | |
120 pill | 7,5mg | NZD227.09 | NZD1.89 | |
90 pill | 7,5mg | NZD181.66 | NZD2.01 | |
60 pill | 7,5mg | NZD132.45 | NZD2.20 | |
30 pill | 7,5mg | NZD75.67 | NZD2.46 | |
Dosage: 15mg | ||||
360 pill | 15mg | NZD681.35 | NZD1.89 | |
270 pill | 15mg | NZD529.93 | NZD1.97 | |
180 pill | 15mg | NZD374.72 | NZD2.08 | |
120 pill | 15mg | NZD276.30 | NZD2.31 | |
90 pill | 15mg | NZD223.31 | NZD2.50 | |
60 pill | 15mg | NZD174.09 | NZD2.88 | |
30 pill | 15mg | NZD102.17 | NZD3.41 |

Mobic Description
Overview of Mobic
Mobic, known generically as meloxicam, is a non-steroidal anti-inflammatory drug (NSAID) commonly used to relieve pain and reduce inflammation. In New Zealand, Mobic is prescribed for various conditions such as osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders. Its targeted action helps decrease inflammation in affected joints, providing much-needed relief for many patients struggling with chronic pain.
How Mobic Works
This medication works by inhibiting certain enzymes in the body called cyclooxygenases (COX-1 and COX-2). These enzymes play a key role in producing prostaglandins, which are chemicals linked to pain, swelling, and fever. By blocking these enzymes, Mobic effectively reduces inflammation and alleviates discomfort. It is designed to be more selective towards COX-2, which means it tends to cause fewer stomach issues compared to some older NSAIDs.
Usability and Dosage in New Zealand
In New Zealand, Mobic is typically available by prescription, and the dosage depends on the severity of the condition and individual health factors. Usually, adults are prescribed a daily dose ranging from 7.5 mg to 15 mg. It is important to follow the prescribing doctor's instructions carefully. For optimal results, the medication should be taken with food or milk to minimize potential stomach upset, which can be a common side effect of NSAIDs.
Effectiveness and Patient Feedback
Many patients in New Zealand report significant improvement in symptoms after beginning Mobic therapy. People with osteoarthritis, in particular, find that it helps reduce joint pain and stiffness, allowing for improved mobility. Rheumatoid arthritis sufferers often experience a decrease in inflammation and swelling. However, individual responses vary; some might notice only mild relief, while others experience a dramatic difference.
Possible Side Effects and Risks
Although Mobic is generally well tolerated, it can cause side effects. Common issues include stomach pain, nausea, and indigestion. More serious but less common adverse reactions may involve gastrointestinal bleeding, cardiovascular problems, or kidney issues. It is especially important for patients in New Zealand to report any unusual symptoms to their healthcare provider. People with pre-existing heart conditions or kidney impairment should use Mobic cautiously under medical supervision.
Precautions and Interactions
Before taking Mobic, patients should inform their healthcare provider about all other medications they are using. Certain drugs, such as blood thinners, other NSAIDs, or corticosteroids, can increase the risk of bleeding or other complications. It is also advisable to avoid alcohol while on Mobic, as it can increase stomach irritation. Regular monitoring may be necessary for those on long-term therapy, particularly for kidney and liver function.
Availability through New Zealand Online Pharmacies
In New Zealand, Mobic can be conveniently purchased via licensed online pharmacies, provided you have a prescription from a healthcare professional. Buying online offers added convenience, especially for those with mobility issues or living in remote areas. Make sure to choose reputable pharmacies to ensure the medication’s authenticity and safety. Always adhere to the prescribed doses and consult your doctor if you experience any side effects or concerns.